Insider · CIK 0001572000
David Charles Lubner
director
Files at CBIO (CRESCENT BIOPHARMA, INC.), ACLX (Arcellx, Inc.), VOR (Vor Biopharma Inc.), DYN (Dyne Therapeutics, Inc.), CRGX (CARGO Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | CRGX CARGO Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Aug 19, 2025 |
| Jun 23, 2025 | CBIO CRESCENT BIOPHARMA, INC. | AGrant or award Stock Option (Right to Buy)derivative | +9,023 | $0.00 | $0 | 9,023 | Jun 23, 2025 |
| Jun 18, 2025 | CRGX CARGO Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 20, 2025 |
| May 30, 2025 | DYN Dyne Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 3, 2025 |
| May 29, 2025 | ACLX Arcellx, Inc. | AGrant or award Stock Option (right to buy)derivative | +9,174 | $0.00 | $0 | 9,174 | May 30, 2025 |
| May 22, 2025 | VOR Vor Biopharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.